共 50 条
- [32] IS THERE STANDARD CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (04): : 369 - 371
- [33] A PROSPECTIVE RANDOMIZED TRIAL OF COMBINATION VINDESINE AND CISPLATIN VERSUS SINGLE-AGENT VINDESINE IN ADVANCED NON-SMALL CELL LUNG-CANCER PHARMACOTHERAPY, 1985, 5 (01): : 20 - 22
- [34] VINDESINE WITH CISPLATIN IN NON-SMALL CELL LUNG-CANCER (NSCLC) - THE INFLUENCE ON SURVIVAL AND THE EFFECT OF ADDING CONVENTIONAL AGENTS PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 521 - 521
- [35] COMBINATION CHEMOTHERAPY WITH CISPLATIN, ETOPOSIDE, AND VINDESINE IN NON-SMALL CELL LUNG-CARCINOMA - A CLINICAL-TRIAL OF THE EORTC LUNG-CANCER WORKING PARTY CANCER TREATMENT REPORTS, 1983, 67 (7-8): : 727 - 730
- [36] VINDESINE AND MITOMYCIN-C IN INOPERABLE NON-SMALL CELL LUNG-CANCER EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (08): : 983 - 985
- [37] PHASE II STUDY OF VINDESINE IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER JAPANESE JOURNAL OF CANCER RESEARCH, 1985, 76 (09): : 902 - 905